Position in NVS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$132,271
-$509,737 QoQ
Shares Held
844
-79.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,350
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,271 | 844 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $642,008 | 4,203 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $663,430 | 4,812 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,320,359 | 10,296 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,254,268 | 10,365 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,155,490 | 10,365 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,025,550 | 10,539 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,228,298 | 10,679 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,094,195 | 10,278 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $986,839 | 10,202 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,035,447 | 10,255 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,044,574 | 10,255 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,034,832 | 10,255 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $952,016 | 10,348 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $925,525 | 10,202 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $775,454 | 10,202 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $862,375 | 10,202 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $895,225 | 10,202 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $772,097 | 8,827 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $834,319 | 10,202 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $930,830 | 10,202 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $872,066 | 10,202 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $963,374 | 10,202 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $888,296 | 10,215 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $894,885 | 10,246 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $831,096 | 10,080 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||